Introduction:Beside its autonomic functions, the nucleus paragigantocellularis lateralis (LPGi) is involved in the descending pain modulation. 17β-Estradiol is a neuroactive steroid found in several brain areas such as LPGi. Intra-LPGi microinjection of 17β-estradiol can elicit the analgesic responses. 17β-Estradiol modulates nociception by binding to estrogenic receptors as well as allosteric interaction with other membrane-bound receptors like GABAA receptors. This study aimed to examine the role of GABAA receptors in the pain modulating effect of intra-LPGi injection of 17β-estradiol.Methods:To study the antinociceptive effects of 17β-estradiol, cannulation into the LPGi nucleus of male Wistar rats was performed. About 500 nL of drug was administered 15 minutes prior to formalin injection (50 μL of 4%). Then, formalin-induced flexing and licking behaviors were recorded for 60 minutes. For evaluating the role of GABAA receptors in the estradiol-induced pain modulation, 17β-estradiol was administered into the LPGi nucleus 15 minutes after the injection of 25 ng/μL bicuculline (the GABAA receptor antagonist). Then, the formalin-induced responses were recorded.Results:The results of the current study showed that intra-LPGi injection of 17β-estradiol decreased the flexing duration in both phases of formalin test (P<0.001); but it only attenuated the second phase of licking behavior (P<0.001). 17β-estradiol attenuated the second phase of formalin test of both behaviors (P<0.001). Bicuculline prevented the antinociceptive effect of intra-LPGi 17β-estradiol in both first and second phases of formalin-induced responses (P<0.001).Conclusion:According to the results of this study, the analgesic effect of intra-LPGi 17β-estradiol on the formalin-induced inflammatory pain might be mediated via GABAA receptors.
Studies have previously demonstrated a relationship between social status and anxiety disorders such as panic disorder.
Repeated episodes of panic attacks do not occur in combination with an actual fear stimulus or stressor. However, social
ranking modulates the perception of the social signals of a threat or stressor. The hypothalamic nuclei are well‑known for their
role in the elaboration of fear‑induced reactions. The dorsomedial hypothalamus (DMH) and the ventromedial hypothalamic
(VMH) nuclei are hypothalamic subnuclei involved in the processing of threatening stimuli‑evoked aversive response and innate
fear development. These structures are also located in the medial amygdala‑hypothalamus‑brainstem circuit that modulates
innate fear‑induced defensive behaviors. This work aimed to investigate the relationship between social hierarchy and innate
fear‑induced panic‑like responses in male rats. In our study, the dominance tube test was used to determine the social hierarchy.
Then, DMH/VMH nuclei were unilaterally implanted with a guide cannula. After intra‑DMH/VMH injection of bicuculline (GABAA
receptor antagonist), both innate fear induction and differences in dominant/subordinate rats were evaluated by the open field
test. Intra‑DMH/VMH bicuculline increased the frequency of defensive immobility, forward escape movements, and crossing
behaviors, as well as the duration of defensive immobility and forward escape movements in dominant rats. Subordinate
rats showed a higher frequency of defensive attention, defensive immobility, and crossing than dominant rats. Additionally,
dominant rats demonstrated a lower duration of defensive attention and defensive immobility than subordinate rats. Dominant
rats seemed to adopt a form of innate‑fear characterized by increased proactivity with the environment. In contrast, subordinate
rats exhibited a reactive form of innate‑fear characterized by passivity and freezing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.